XTSE
XTG
Market cap88mUSD
Sep 16, Last price
2.65CAD
1D
-0.75%
1Q
-1.85%
Jan 2017
1,004.17%
IPO
35.90%
Name
Xtra Gold Resources Corp
Chart & performance
P/E
23.49
P/S
—
EPS
0.08
Div yield, %
—
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
%
Revenues
0
Net income
4m
+123.70%
CFO
1m
-48.67%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Xtra-Gold Resources Corp. is dedicated to identifying and developing gold deposits across Ghana, West Africa. The company's extensive land holdings for mining span 225.87 square kilometers, which include several key ventures: the Kibi project (33.65 sq km), the Banso project (51.67 sq km), the Muoso project (55.28 sq km), the Kwabeng project (44.76 sq km), and the Pameng project (40.51 sq km). Founded in 1998, the corporation operated as RetinaPharma International, Inc. until it adopted its current name, Xtra-Gold Resources Corp., in December 2003. Its main office is located in Nassau, Bahamas.
Key people
James Werth Longshore
Chairman of the Board, Chief Executive Officer · since 2015
Vice President - Exploration · since 2006
Victor Nkansa
Chief Financial Officer, Vice President - Ghana Operations · since 2015
Denis Roland Laviolette
Director · since 2015
Peter C. Minuk
Corporate Secretary, Director · since 2015
Hans Morsches
Director · since 2015
James Harold Schweitzer
Independent Director · since 2011
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||